Physician

Eric D Challgren, M.D.

According to 2025 Medicare claims, Eric Challgren, M.D. (NPI: 1477508893) practices micrographic dermatologic surgery in the Raleigh-Cary, NC market, with the plurality of this provider's patient population coming from Wake, NC. This provider's primary affiliated billing organization is SOUTHERN DERMATOLOGY, P.A. (NPI: 1568415586; TIN: 22-3864190) and primary practice location at 27607-7511.

Challgren's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 889 traditional Medicare patients, billed 5,492 HCPCS/CPT codes, and received $367,386 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,681 prescription claims across 605 beneficiaries totaling $777,640 in drug costs, led by Cosentyx Sensoready (2 Pens) (Secukinumab). Open Payments data shows 252 records totaling $7,357. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $182,302 to $777,640. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$201K$402K2015 Medicare payment: $401,860 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $358,904 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $318,901 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $322,327 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $358,376 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $356,749 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $364,389 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $324,969 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $349,739 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $367,386 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,0296,151$401,860
20169666,087$358,904
20179635,576$318,901
20189205,595$322,327
20198545,913$358,376
20207225,410$356,749
20217946,207$364,389
20228165,178$324,969
20238925,897$349,739
20248895,492$367,386

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$456K$911K2015 Drug cost: $182,302 (USD; Tot_Drug_Cst)2016 Drug cost: $447,391 (USD; Tot_Drug_Cst)2017 Drug cost: $543,330 (USD; Tot_Drug_Cst)2018 Drug cost: $546,413 (USD; Tot_Drug_Cst)2019 Drug cost: $669,553 (USD; Tot_Drug_Cst)2020 Drug cost: $911,297 (USD; Tot_Drug_Cst)2021 Drug cost: $868,242 (USD; Tot_Drug_Cst)2022 Drug cost: $706,759 (USD; Tot_Drug_Cst)2023 Drug cost: $743,418 (USD; Tot_Drug_Cst)2024 Drug cost: $777,640 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015389948$182,302
2016374917$447,391
2017375918$543,330
2018404968$546,413
20194251,145$669,553
20204191,260$911,297
20214101,350$868,242
20224221,264$706,759
20235331,516$743,418
20246051,681$777,640

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths215246$75
11102Biopsy of related skin growth, first growth204240$63
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more673906$58
17000Destruction of precancer skin growth, 1 growth342428$37
17003Destruction of precancer skin growth, 2-14 growths2721,434$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Cosentyx Sensoready (2 Pens)Secukinumab22616$159,583
RinvoqUpadacitinib15450$112,076
ValchlorMechlorethamine Hcl11330$65,632
Dupixent PenDupilumab12322$44,860
Doxycycline Ir-DrDoxycycline Monohydrate22765$16,228

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.252$7,357E.R. Squibb & Sons, L.L.C.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Eric D. Challgren, M.D.?

Tedicare shows public-source Medicare data for Eric D. Challgren, M.D. (NPI 1477508893), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Eric D. Challgren, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Eric D. Challgren, M.D.?

Eric D. Challgren, M.D. is linked to SOUTHERN DERMATOLOGY, P.A. (billing NPI 1568415586) in the available physician profile data.

Does Eric D. Challgren, M.D. have Open Payments data?

Eric D. Challgren, M.D. has 252 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.